Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 018312/0647 | |
| Pages: | 5 |
| | Recorded: | 09/27/2006 | | |
| Attorney Dkt #: | 24852 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
6
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
10379149
|
Filing Dt:
|
03/04/2003
|
|
Publication #:
|
|
Pub Dt:
|
04/15/2004
| | | | |
|
Title:
|
Methods of inducing terminal differentiation
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
10567952
|
Filing Dt:
|
11/17/2006
|
|
Publication #:
|
|
Pub Dt:
|
03/15/2007
| | |
PCT #:
|
US0427943
|
|
Title:
|
Methods of treating cancer with hdac inhibitors
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
10567953
|
Filing Dt:
|
01/03/2007
|
|
Publication #:
|
|
Pub Dt:
|
08/16/2007
| | |
PCT #:
|
US0426161
|
|
Title:
|
Combination Methods of Treating Cancer
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/15/2008
|
Application #:
|
10616649
|
Filing Dt:
|
07/09/2003
|
|
Publication #:
|
|
Pub Dt:
|
07/01/2004
| | | | |
|
Title:
|
METHODS OF TREATING CANCER WITH HDAC INHIBITORS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/12/2006
|
Application #:
|
10650025
|
Filing Dt:
|
08/26/2003
|
|
Publication #:
|
|
Pub Dt:
|
05/06/2004
| | | | |
|
Title:
|
METHODS OF TREATING MESOTHELIOMA WITH SUBEROYLANILIDE HYDROXAMIC ACID
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
10665079
|
Filing Dt:
|
09/16/2003
|
|
Publication #:
|
|
Pub Dt:
|
07/01/2004
| | | | |
|
Title:
|
Methods of treating cancer with HDAC inhibitors
|
|
|
Assignee
|
|
|
|
|
| 33 AVENUE LOUIS PASTEUR |
| BOSTON, MASSACHUSETTS 02115 |
|
|
Correspondence name and address
|
| |
MINTZ LEVIN COHN FERRIS GLOVSKY ET AL.
|
| |
666 THIRD AVENUE, 24TH FLOOR
|
| |
NEW YORK, NY 10017
|
Search Results as of:
06/24/2024 04:25 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
